Companies/EU/GVS

GVS S.P.A.

Income flow

Annual
GVS ANNUAL Income StatementPeriod 2025-12-31Source ANNUAL
MedtechEUR 215MSafetyEUR 83MTransfusion MedicineEUR 58MEnergy & MobilityEUR 57MLife SciencesEUR 12MRevenueEUR 433M-1% Y/YOperating profitEUR 58M-8% Y/YOperating costsEUR 375MPre-tax profitEUR 26MOther expensesEUR 32MNet profitEUR 18M-45% Y/YTaxEUR 7M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-12-31 · ANNUAL · EUR
By activity
By activityEUR 425M
  • MedtechEUR 215M50.7%
  • SafetyEUR 83M19.5%
  • Transfusion MedicineEUR 58M13.6%
  • Energy & MobilityEUR 57M13.4%
  • Life SciencesEUR 12M2.9%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.0.0%Shares outTotal shares currently outstanding (issued and not retired).183.1MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).68.1M
Dividend calendar
Ex-dividend
2021-06-21
Last cash
0.13 · 2021-06-21